Optimizing Heart Failure Management in the Cardio-Oncology Setting: Guideline-Directed Medical Therapy, Permissive Cardiotoxicity, and Personalized Approaches
Crossref DOI link: https://doi.org/10.1007/s12170-025-00780-x
Published Online: 2025-12-03
Published Print: 2025-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Golob, Stephanie
Zhou, Sophia
Moussa, Mohamed
Bloom, Michelle
Text and Data Mining valid from 2025-12-01
Version of Record valid from 2025-12-01
Article History
Received: 14 October 2025
Accepted: 22 October 2025
First Online: 3 December 2025
Declarations
:
: The authors declare no competing interests.